| Title |
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
|
|---|---|
| Published in |
Nature Chemical Biology, August 2012
|
| DOI | 10.1038/nchembio.1060 |
| Pubmed ID | |
| Authors |
Dimitrios Anastasiou, Yimin Yu, William J Israelsen, Jian-Kang Jiang, Matthew B Boxer, Bum Soo Hong, Wolfram Tempel, Svetoslav Dimov, Min Shen, Abhishek Jha, Hua Yang, Katherine R Mattaini, Christian M Metallo, Brian P Fiske, Kevin D Courtney, Scott Malstrom, Tahsin M Khan, Charles Kung, Amanda P Skoumbourdis, Henrike Veith, Noel Southall, Martin J Walsh, Kyle R Brimacombe, William Leister, Sophia Y Lunt, Zachary R Johnson, Katharine E Yen, Kaiko Kunii, Shawn M Davidson, Heather R Christofk, Christopher P Austin, James Inglese, Marian H Harris, John M Asara, Gregory Stephanopoulos, Francesco G Salituro, Shengfang Jin, Lenny Dang, Douglas S Auld, Hee-Won Park, Lewis C Cantley, Craig J Thomas, Matthew G Vander Heiden |
| Abstract |
Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 29% |
| United Kingdom | 1 | 14% |
| Spain | 1 | 14% |
| United States | 1 | 14% |
| Unknown | 2 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Science communicators (journalists, bloggers, editors) | 1 | 14% |
| Scientists | 1 | 14% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 1% |
| United Kingdom | 5 | <1% |
| China | 4 | <1% |
| Japan | 3 | <1% |
| India | 3 | <1% |
| Korea, Republic of | 2 | <1% |
| Germany | 2 | <1% |
| Netherlands | 1 | <1% |
| Italy | 1 | <1% |
| Other | 3 | <1% |
| Unknown | 599 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 133 | 21% |
| Researcher | 106 | 17% |
| Student > Master | 57 | 9% |
| Student > Bachelor | 46 | 7% |
| Student > Doctoral Student | 43 | 7% |
| Other | 111 | 18% |
| Unknown | 136 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 158 | 25% |
| Biochemistry, Genetics and Molecular Biology | 133 | 21% |
| Medicine and Dentistry | 57 | 9% |
| Chemistry | 47 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 3% |
| Other | 52 | 8% |
| Unknown | 165 | 26% |